Received May 5, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z005153 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Z003767 | — |
no adverse event; HCP reports that the patient received both VARIVAX and PROQUAD on the same day; This Spontaneous report was received from Nurse and referred to a patient of unknown age and gender. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On 29-Apr-2026, the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) powder and solvent for solution for injection (VARIVAX) (0.50 mL) (total) (Batch/Lot Number: Z003767) (Expiration date: 30-Jan-2027) with sterile diluent solution for injection. On 29-Apr-2026, the patient was vaccinated with MMR and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (0.50 mL) (total) (Batch/Lot Number: Z005153) (Expiration date: 25-Aug-2026) with sterile diluent solution for injection. All were for prophylaxis (Overdose). No adverse event was reported (No adverse event).
Sterile Diluent